| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/11/2006 | US7074578 identifying transcriptionally active chromatin by contacting chromatin with an antibody that binds to a histone H3 polypeptide which is trimethylated at Lys4, anddetermining the presence or absence of binding of the antibody to the chromatin |
| 07/11/2006 | US7074573 CLCKb mutation as a diagnostic therapeutical target |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074569 Mobility-modified nucleobase polymers and methods of using same |
| 07/11/2006 | US7074568 using primers generated to the internal transcribed spacer sequence of 16S-23S rDNA that specifically amplify mycobacteria other than tuberculosis (MOTT); kits |
| 07/11/2006 | US7074567 Assay for human DNA for gender determination |
| 07/11/2006 | US7074566 Determining interference or disturbance in the co-modulation mechanism between androgen receptor proteins and the coactivator arginine methyltransferase (HSRNAAM) |
| 07/11/2006 | US7074565 Preparation of DNA-containing extract for PCR amplification |
| 07/11/2006 | US7074564 Rolling circle replication of padlock probes |
| 07/11/2006 | US7074563 Mass spectrometric methods for detecting mutations in a target nucleic acid |
| 07/11/2006 | US7074562 Ghrelin alleles and use of the same for genetically typing animals |
| 07/11/2006 | US7074561 Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA |
| 07/11/2006 | US7074559 Comprises nucleotide sequences coding mycobacterium paratuberculosis polypeptides for immunization and prevention of mycobacterial animal infections |
| 07/11/2006 | US7074558 Nucleic acid amplification using an RNA polymerase and DNA/RNA mixed polymer intermediate products |
| 07/11/2006 | US7074557 Isolating preferentially binding particles; obtain nucleotide sequences, incubate with translation appataratus, expose to preferential particles, recover encapsulated complex |
| 07/11/2006 | US7074556 Generating preferential nucleotide sequences; obtain mesenger ribonucleic acids, mix with polymerase, incubate, recover nucleotide sequences |
| 07/11/2006 | US7074555 contacting the biological sample with an immobilized anti-IgM antibody and a labeled West Nile virus E polypeptide, and detecting whether the polypeptide substantially binds to an antibody in the sample |
| 07/11/2006 | US7074554 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 07/11/2006 | US7074553 Retrovirus associated with myelodysplastic syndromes and uses thereof |
| 07/11/2006 | US7074410 Modified HCV peptide vaccines |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074367 Thermostated block with heat-regulating devices |
| 07/11/2006 | US7074365 Detector for halogen toxicants and method |
| 07/11/2006 | US7073246 Method of making a biosensor |
| 07/11/2006 | CA2499049C Method of making sensor electrodes |
| 07/11/2006 | CA2352490C Magnetic particles for purifying nucleic acids |
| 07/11/2006 | CA2335387C Method for analyzing phyletic lineage of scallop |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/07/2006 | CA2512667A1 Human hepatocyte-like cells and uses thereof |
| 07/06/2006 | WO2006072089A1 Analyte sensor and method of manufacturing the same |
| 07/06/2006 | WO2006072075A2 Genetic markers of schizophrenia |
| 07/06/2006 | WO2006072033A2 Particle-based multiplex assay system with three or more assay reporters |
| 07/06/2006 | WO2006071949A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 07/06/2006 | WO2006071896A2 Epitope-based sars vaccine |
| 07/06/2006 | WO2006071843A2 Biomarkers for breast cancer |
| 07/06/2006 | WO2006071840A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 07/06/2006 | WO2006071776A2 Ligation-based rna amplification |
| 07/06/2006 | WO2006071746A2 Engineered dopamine neurons and uses thereof |
| 07/06/2006 | WO2006071583A2 Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| 07/06/2006 | WO2006071582A2 Methods, compositions, and kits for forming self-complementary polynucleotides |
| 07/06/2006 | WO2006071568A2 Methods, compositions, and kits for forming labeled polynucleotides |
| 07/06/2006 | WO2006071563A2 Non-tumorigenic mdck cell line for propagating viruses |
| 07/06/2006 | WO2006071410A2 Apparatus and system having dry gene silencing compositions |
| 07/06/2006 | WO2006071372A1 Virus preparations and methods |
| 07/06/2006 | WO2006071247A2 Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots |
| 07/06/2006 | WO2006071241A2 Compositions for use in identification of bacteria |
| 07/06/2006 | WO2006071088A1 Markers for the diagnosis of aml, b-all and t-all |
| 07/06/2006 | WO2006070946A1 A method for analyzing nucleobases on a single molecular basis |
| 07/06/2006 | WO2006070901A1 Method of detecting repeated polymorphism in human heparin/heparan sulfate binding protein and utilization of the same |
| 07/06/2006 | WO2006070860A1 Novel screening method for inflammatory cytokine inhibitor |
| 07/06/2006 | WO2006070815A1 Fusarium toxin resistant transformed plant |
| 07/06/2006 | WO2006070804A1 Method of inhibiting telomerase activity and inhibitor |
| 07/06/2006 | WO2006070775A1 System for biosynthesis of firefly luminescence substrates with natural l-cysteine or derivatives thereof and luminescence substrate solutions containing the system |
| 07/06/2006 | WO2006070729A1 Insulin-producing cell-specific promoter and the use thereof |
| 07/06/2006 | WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | WO2006070667A1 Method of detecting mutation in egfr gene and detection kit |
| 07/06/2006 | WO2006070666A1 Method of simultaneously detecting gene polymorphisms |
| 07/06/2006 | WO2006070348A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY |
| 07/06/2006 | WO2006070180A1 Detection of phosphoproteins |
| 07/06/2006 | WO2006069907A1 Compositions and methods for treating schizophrenia and related disorders |
| 07/06/2006 | WO2006069638A1 Nucleic acid-binding chips for the detection of phosphate deficiency conditions in the framework of bioprocess monitoring |
| 07/06/2006 | WO2006069592A2 Method for diagnosing an/or predicting preeclampsia and/or related disorders |
| 07/06/2006 | WO2006069537A1 The optimum method of amplification on polymerase chain reaction |
| 07/06/2006 | WO2006069449A1 Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
| 07/06/2006 | WO2006069413A2 Method for isolating cells and viruses |
| 07/06/2006 | WO2006055521A3 Tirf single molecule analysis and method of sequencing nucleic acids |
| 07/06/2006 | WO2006052419A3 Nucleic acid enzyme light-up sensor utilizing invasive dna |
| 07/06/2006 | WO2006048467A3 Animal models comprising at least one transgene and one sequence enabling the controlled expression of an rna interfering with this transgene |
| 07/06/2006 | WO2006046073A3 C1q related protein |
| 07/06/2006 | WO2006043095A3 Monitoring enzyme-substrate reactions |
| 07/06/2006 | WO2006043060A3 Mam domain containing protein |
| 07/06/2006 | WO2006033088A3 Genomic assay |
| 07/06/2006 | WO2006026614A3 Method of error reduction in nucleic acid populations |
| 07/06/2006 | WO2006019407A3 Method for detecting and quantifying rare mutations/polymorphisms |
| 07/06/2006 | WO2006017833A3 Genetic loci associated with phytophthora tolerance in soybean |
| 07/06/2006 | WO2006016525A3 Genes and polypeptides relating to breast cancers |
| 07/06/2006 | WO2006014335A3 Compositions and methods for treatment of non-hodgkin’s lymphoma |
| 07/06/2006 | WO2006010146A3 Functional variant of lymphoid tyrosine phosphatase is associated with autoimmune disorders |
| 07/06/2006 | WO2006007751A3 Metabolic method to identify flavours and/or fragrances |
| 07/06/2006 | WO2006007472B1 Non-invasive glucose measurement |
| 07/06/2006 | WO2006004634A3 Citrus sudden death |
| 07/06/2006 | WO2005116252A8 Methods for evaluating ribonucleotide sequences |
| 07/06/2006 | WO2005116250A3 Viral and viral associated mirnas and uses thereof |
| 07/06/2006 | WO2005111231A3 Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities |
| 07/06/2006 | WO2005106035A3 Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use |
| 07/06/2006 | WO2005097993A3 Immunostimulatory viral rna oligonucleotides |
| 07/06/2006 | WO2005085451A3 Polynucleotide phosphorylase (pnpase) as target for herbicides |
| 07/06/2006 | WO2005081867A3 Salivary mrna profiling, biomarkers, and related methods and kits of parts |
| 07/06/2006 | WO2005076999A3 Methods and compositions for combination rnai therapeutics |
| 07/06/2006 | WO2005076939A3 Assay and method for diagnosing and treating alzheimer’s disease |
| 07/06/2006 | WO2005062744A3 Counting biological agents on biological growth plates |
| 07/06/2006 | WO2005049798A3 Chromosome 5 genetic variants related to dyslexia |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2005040757A3 Test for early detection of viral infection |
| 07/06/2006 | WO2005017118A3 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 07/06/2006 | WO2005017111A3 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 07/06/2006 | WO2005017104A3 Cancer-linked gene as target for chemotherapy |
| 07/06/2006 | WO2005003326A3 Artificial receptors including reversibly immobilized building blocks and methods |
| 07/06/2006 | WO2004101761A3 METHODS FOR THE IDENTIFICATION OF INHIBITORS OF CAX1-LIKE Ca+2/H+ANTIPORTER ACTIVITY IN PLANTS |